Carregant...
Anti-malarial drug safety information obtained through routine monitoring in a rural district of South-Western Senegal
BACKGROUND: Knowing the safety profile of anti-malarial treatments in routine use is essential; millions of patients receive now artemisinin combination therapy (ACT) annually, but the return on information through current systems is as yet inadequate. Cohort event monitoring (CEM) is a WHO (World H...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3548733/ https://ncbi.nlm.nih.gov/pubmed/23216982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-11-402 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|